Classical prediction analysis of microarray 50 (PAM50) classifies breast cancer into luminal A, luminal B, HER2+, and basal-like subtypes according to the expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 (28, 29). Here, ERBB2 is linked to breast cancer.